Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma
Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page
- Check6 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and a new record revision (v3.6.0) was added, replacing the prior revision (v3.5.5).SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now shows the latest revision tag, v3.5.5, replacing the previous v3.5.4, indicating an incremental update to the page’s interface.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the revision history, and the previous 'Revision: v3.5.3' entry was removed. This updates the history to reflect the latest site revision.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study record history now includes a newer submitted version dated 2026-04-21 and associated “more information” and results-related sections, indicating the trial’s core metadata and reporting content were updated. It replaces an earlier revision (v3.5.2) reference with the latest revision (v3.5.3), consistent with an updated ClinicalTrials.gov record version.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded revision v3.5.2 and deleted revision v3.5.0.SummaryDifference0.0%

- Check92 days agoChange DetectedIn the log, Revision: v3.5.0 was added and Revision: v3.4.3 was crossed out.SummaryDifference0.0%

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma
Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.